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Abstract 
Despite evidence for beneficial use of methylphenidate in response inhibition, no studies so 
far have investigated the effects of this drug in the neurobiology of inhibitory control in 
traumatic brain injury (TBI), even though impulsive behaviours are frequently reported in 
this patient group. We investigated the neural basis of response inhibition in a group of TBI 
patients using functional magnetic resonance imaging and a stop-signal paradigm. In a 
randomised double-blinded crossover study, the patients received either a single 30 mg dose 
of methylphenidate or placebo and performed the stop-signal task. Activation in the right 
inferior frontal gyrus (RIFG), an area associated with response inhibition, was significantly 
lower in patients compared to healthy controls. Poor response inhibition in this group was 
associated with greater connectivity between the RIFG and a set of regions considered to be 
part of the default mode network (DMN), a finding that suggests the interplay between DMN 
and frontal executive networks maybe compromised. A single dose of methylphenidate 
rendered activity and connectivity profiles of the patients RIFG near normal. The results of 
this study indicate that the neural circuitry involved in response inhibition in TBI patients 
may be partially restored with methylphenidate. Given the known mechanisms of action of 
methylphenidate, the effect we observed may be due to increased dopamine and 
noradrenaline levels.  
Keywords: Traumatic Brain Injury, Response inhibition, Functional connectivity, 
Methylphenidate 
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1. Introduction 
Although methylphenidate has an established beneficial effect over many of the cognitive 
functions typically impaired after traumatic brain injury (TBI) (Bales et al., 2009; Kim et al., 
2006), the study of its effects on the neurobiological basis of response inhibition has not been 
assessed in this population even though impulsive behaviours and poor inhibitory control are 
frequently reported in patients with TBI. Such behavioural patterns not only have numerous 
repercussions on the patients’ and relatives’ quality of life but also have a negative impact on 
the rehabilitation process (Rochat et al., 2010). Moreover, despite the evidence for the 
beneficial use of methylphenidate in response inhibition paradigms in psychiatric and healthy 
populations (e.g., Aron et al., 2003; Rubia et al., 2014), no studies so far have investigated the 
effects of methylphenidate on the neurobiological basis of response inhibition in TBI 
patients.  
In the context of response inhibition, the right inferior frontal gyrus (RIFG) has been 
postulated to be the main area associated with cognitive control (Aron et al., 2014). 
Nevertheless, high-level cognitive functions such as response inhibition require the 
integration of information across spatially distinct brain regions and therefore diffuse axonal 
injury (DAI) and its effect on long-range white matter tracts may be responsible for the 
compromised response inhibition found in TBI populations (Sharp et al., 2014). In this sense, 
the coordinated activity of large-scale brain networks such as the central executive, the 
salience and the default mode networks (DMN) seems to be necessary for efficient inhibitory 
control (Sharp et al., 2014). Studies of these networks in TBI populations have reported 
abnormally increased DMN connectivity as well as reduced connectivity between salience 
and DMN during the execution of response inhibition tasks (Hillary et al., 2011; Jilka et al., 
2014; Pandit et al., 2013; Sharp et al., 2011; Tang et al., 2012; Venkatesan et al., 2015). 
Interestingly, the failure to regulate the activity/connectivity of the DMN or the lack of 
Page | 4  
 
deactivation of this network during the execution of inhibition tasks has been associated with 
slower and less successful inhibitory control (Bonnelle et al., 2012; Raichle and Snyder, 
2007; Zhang and Li, 2012) 
In this study we investigated the neural basis of response inhibition in a sample of 
TBI patients and an age-matched control group using functional magnetic resonance imaging 
and a stop-signal paradigm. In a randomised double-blinded crossover study, the patients 
received either a single 30 mg dose of methylphenidate or placebo and performed the stop-
signal task. Healthy controls (HC) underwent the same protocol without methylphenidate. 
We hypothesize that chronic TBI patients will show reduced activity in the areas associated 
with inhibitory control (e.g., inferior frontal gyrus) and that the use of a single dose of 
methylphenidate will restore the functionality of these regions by increasing dopamine and 
noradrenaline levels (Chamberlain et al., 2007, 2009).  
2. Experimental procedures 
2.1. Participants 
Fourteen chronic TBI patients and 20 HC met the study inclusion criteria. TBI patients were 
referred from the Addenbrooke’s Neurosciences Critical Care Unit Follow-Up Clinic, the 
Addenbrooke’s Traumatic Brain Injury Clinic and the Royal London Hospital Intensive Care 
Unit. Only patients with DAI, as opposed to focal lesions, were included in this study. They 
were at least 7 months post TBI (mean 20.79 ± 11.78 months) and were not receiving any 
acute hospital interventions. They sustained moderate to severe TBI –as measured by the 
Glasgow Coma Scale (GCS) (Teasdale and Jennett, 1974), the Injury Severity Scale (ISS) 
(Baker et al., 1974) and the Acute Physiology and Chronic Health Evaluation II (APACHE 
II) (Knaus et al., 1985). Lesion information of the patients is presented in Supplementary 
Table 1. HCs were recruited via advertisements in Addenbrooke’s Hospital and in the local 
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Cambridge area and were paid for their participation. Both HCs and TBI patients were 
screened by exclusion criteria including National Adult Reading Test < 70, Mini Mental State 
Exam < 23, left-handedness, history of psychiatric or neurologic disorders, contraindications 
for MRI scanning, taking medication that may affect their physical or cognitive performance, 
history of drug or alcohol abuse and pregnancy or nursing. Additionally, patients were 
excluded if they had a physical disability that could prevent them from completing the tasks 
either in the screening or scanning stages. Demographic and characteristics of the samples are 
summarized in Table 1.  
2.2. Testing protocols and procedures 
This study was approved by the local Research Ethics Committee and exempted from 
Clinical Trials status by the United Kingdom’s Medicines and Healthcare products 
Regulatory Authority. All participants provided written informed consent and healthy 
controls received monetary compensation for their participation. The testing protocol 
included two visits separated by 2-4 weeks. During the first visit and prior to receiving any 
medication, a series of background assessments and a baseline cognitive assessment (lasting 
approximately 60 minutes) were carried out in both groups, outside the scanner. We used a 
cognitive battery designed to measure several aspects of executive function plus reaction time 
through well-validated tests. MRI scanning was carried out during both visits and lasted 
approximately 90 minutes. The effects of methylphenidate on the neural substrates of 
response inhibition were assessed in a within-subject, double-blind, crossover, randomized, 
placebo-controlled design, with participants visiting on two occasions. On one of the two 
visits (randomized order) the TBI patients ingested a single capsule containing 30 mg of 
methylphenidate and during the other, a placebo capsule of identical appearance containing 
lactose. The 30-mg dose of methylphenidate was chosen to match the doses used in clinical 
practice and reported in the literature (e.g., Gilbert et al, 2006; Marquand et al., 2011). 
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Patients relaxed for 1.5 hours in a quiet waiting room, before undertaking brain scanning to 
ensure peak plasma levels were reached (Faraj et al., 1974). HC attended their two fMRI 
assessments at the same time interval as for the drug/placebo patient arm of the study, but 
without pharmacological intervention.  
2.3. Instruments 
2.3.1. Executive function tests 
We used a cognitive battery designed to measure several aspect of executive function plus 
attention through well-validated tests. The measures of executive function we used were the 
spatial span test (SSP) and the intra-extra dimensional set shift (IED). Both measures along 
with the measure of simple reaction time (SRT) are part of the Cambridge 
Neuropsychological Test Automated Battery (CANTAB; 
http://www.cambridgecognition.com/). The validity of the CANTAB has been supported by 
numerous studies in patients with brain lesions, neurodegenerative diseases, and psychiatric 
illness (e.g., Chamberlain et al., 2011; Kasahara et al., 2011). The SSP assesses working 
memory capacity. A set of white squares is shown on the screen. Some of the squares change 
in colour, one by one, in a variable sequence. At the end of each sequence a tone indicates 
that the subject should touch each of the boxes coloured by the computer in the same order as 
they were originally presented. The number of squares ranges from two to nine. The analysis 
of the SSP focuses on the spatial span length and total errors. The IED test assesses visual 
discrimination and attentional set formation and maintenance, shifting, and attentional 
ﬂexibility. The test initially presents two simple coloured shapes and the participant must 
determine which one is correct in response to feedback. In successive stages when a criterion 
is reached (i.e., six correct responses), the rules and/or stimuli change, moving from intra-
dimensional, in which coloured shapes remain the only relevant dimension, to extra-
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dimensional, in which the participant needs to shift between white lines and coloured shapes 
as relevant or irrelevant dimensions. Finally, the simple reaction time (SRT) is a test which 
assesses reaction time. It is useful for testing general alertness and motor speed. The 
participant must press a button as soon as he/she sees a white square on the screen.  
2.3.2. Stop-Signal Task 
The stop-signal event-related fMRI paradigm has been described and validated in detail 
elsewhere (Rubia et al., 2003; 2007). All participants received a training session outside the 
scanner to ensure correct understanding of the task instructions. On each trial, a left- or right-
pointing arrow is displayed on a computer screen (white on black background) and volunteers 
are instructed to respond with their right index or middle fingers depending on the arrow 
direction (go trials). In some trials, the arrow is followed by another arrow pointing upwards 
(stop trials) in which case the participants are instructed to stop themselves from pressing any 
buttons. Nevertheless, motor responses are made prepotent by the infrequent nature of stop 
trials. The interval between the onset of the go trial and the onset of the stop trials (i.e., stop-
signal delay -SSD) was set at 150 ms on the first stop trial. From then on, an online tracking 
algorithm adjusted SSD as a function of individual stopping performance (Levitt, 1971). 
After successful inhibition, SSD increased by 50 ms, thereby decreasing the chances of 
successful inhibition on the next stop trial. If the participant was unable to stop (i.e., failed-
inhibition trial), SSD decreased by 50 ms, increasing the chances of stopping. This adaptive 
algorithm ensured  successful  inhibition  on  about  50%  of  the  stop  trials,  a procedure 
that yields reliable estimates of SSRT (Band et al., 2003). The task included 240 trials in 
total, 200 go trials and 40 stop trials. The minimum number of go trials between two stop 
trials was three and the maximum seven. The go stimulus duration in go trials was 1000 ms, 
whereas the stop stimulus duration varied between a minimum of 100 ms and 300 ms. 
Inhibitory control was evaluated using the stop-signal reaction time (SSRT). SSRT was 
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calculated by subtracting mean SSD from the median reaction time on go trials. SSRT thus 
reflects the average time (in ms) that the individual requires in order to successfully inhibit a 
motor response approximately 50% of the time and therefore higher SSRT values are 
indicative of poorer inhibition (Logan et al., 1997).  
2.4. MRI acquisition and pre-processing 
Participants were scanned on a Siemens Trio 3-Tesla MR system (Siemens AG, Munich, 
Germany) at the Wolfson Brain Imaging Centre of Addenbrooke’s Hospital (Cambridge, 
UK). The imaging session started with a localiser followed by a high resolution T1-weighted, 
magnetization-prepared 180 degrees radio-frequency pulses, rapid gradient-echo (MPRAGE) 
structural scan (TR = 2300 ms, TE = 2.98 ms, TA = 9.14 min, flip angle = 9°, FOV = 256 
mm, voxel size = 1.0 x 1.0 x 1.0 mm, slices = 176). DTI data (63 non-collinear directions, b = 
1000 s/mm2 with one volume acquired without diffusion weighting (b = 0), TR = 1700 ms, 
TE = 106 ms, FOV = 192 mm, voxel size = 2.0 x 2.0 x 2.0 mm) were also collected to 
investigate white matter integrity in the TBI group. Finally, the functional data was acquired 
using an EPI (echo-planar imaging) sequence with the following parameters: TR = 2000 ms, 
TE = 30 ms, flip angle = 78⁰, FOV = 192 mm, voxel size = 3.0 x 3.0 x 3.75 mm, slices per 
volume = 32.  
DTI data were eddy current corrected and realigned using FSL 
(fsl.fmrib.ox.ac.uk/fsl/fslwiki/). Fractional anisotropy images were calculated and spatially 
normalised by utilising a study specific template constructed in a manner described by our 
group previously (Stamatakis et al., 2011). The spatially normalised fractional anisotropy 
images were smoothed with an 8 mm isotropic Gaussian filter. Functional MRI data were 
preprocessed using SPM8 (Welcome Department of Cognitive Neurology, 
http://www.fil.ion.ucl.ac.uk/spm/software/spm8/) implemented in MatLab R2007b 
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(Mathworks, Natick, MA, USA). fMRI image preprocessing involved motion correction, 
spatial normalization to the MNI space and smoothing with a 6 mm FWHM Gaussian kernel. 
2.5. Behavioural analyses 
Behavioral data were analysed with the SPSS 21 (Chicago, IL, USA). Independent-sample t-
test and chi-square tests were used to compare the groups on relevant socio-demographic 
variables. Finally, a Kruskal-Wallis test was used to test for differences between groups (HC 
and TBI patients under the placebo and Methylphenidate condition) on the SSRT since the 
scores of the participants were not normally distributed. Because inhibitory control may be 
influenced by other cognitive processes, we also performed bivariate correlations between the 
measure of inhibition we used (SSRT) and simple reaction time (SRT), working memory 
(SSP) and cognitive flexibility (IED) measures, assessed in the group of TBI patients during 
their first visit before the administration of either drug or placebo. Significance threshold was 
set at P < 0.05. 
2.6. Imaging analyses 
2.6.1. DTI Analysis 
Voxel-wise group fractional anisotropy comparisons between HC and TBI patients were 
carried out using a two-sample t-test. The data of one patient and three HCs did not meet our 
quality assessment criteria and were not included in these analyses. Clusters are reported as 
significant if they survived FWE correction for multiple comparisons set at P < 0.05 
(individual voxel threshold was set at P < 0.001 uncorrected). Significant clusters were 
anatomically annotated using the natbrainlab.nii.gz template 
(http://www.mccauslandcenter.sc.edu/mricro/mricron/). 
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2.6.2. fMRI Analysis 
The BOLD response at each voxel was convolved with the canonical hemodynamic response 
function and a high-pass filter was used to remove low-frequency noise (1/120 Hz). The 
conditions of interest were modelled from the onset of the go and no go trials and six 
additional regressors were included in the model accounted for subject movement. We 
defined four conditions of interest based in the participants’ response: go success, go error, 
stop success and stop error. We were interested in studying brain activation for the contrast of 
stop success vs. stop error which served as a measure of inhibitory control. Within group 
activation maps were obtained with one-sample t-tests. Differences between the groups were 
established using two-sample t-tests. We report group differences using small volume 
correction. To avoid circularity we defined a region of interest (ROI) derived from a different 
group of subjects (from the study of Rubia et al., 2003) and included significantly activated 
areas for the contrast of successful inhibition vs. unsuccessful inhibition (or stop success > 
stop error). Statistical significance was established with a combination of voxel- and cluster-
level thresholds. The spatial extent thresholds were determined by 1000 Monte Carlo 
simulations using AlphaSim (Ward, 2000) as implemented in the SPM REST toolbox (Song 
et al., 2011). Input parameters to AlphaSim included a probability voxel-level significance of 
0.005, a cluster connection radius of 5 mm and the smoothness of each T map within our 
ROIs after model estimation. The minimum cluster size to satisfy a P < 0.05 FWE were 207 
voxels for the one-sample t-test and 26 for the two-sample t-test. 
2.6.3. Psychophysiological interactions analysis 
To examine changes in effective connectivity between groups during the experimental task, 
we conducted a Psychophysiological interaction (PPI) analysis which involves the extraction 
of a task specific time-series from an ROI (seed) and the calculation of its interactions with 
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other parts of the brain in a voxel-wise manner. The seed region selected in this instance was 
defined as a 6 mm radius sphere around the significant statistical peaks found from the group 
activity comparison. In this analysis and due to the lack of an a priori hypothesis, input 
parameters to AlphaSim were the same as those we used in the subtractive fMRI analysis but 
including a gray-matter whole brain mask of 163,556 voxels and the actual smoothing of the 
data after model estimation. The minimum cluster size was determined to be 180 voxels for 
the one sample t-test and 174 voxels for the two sample t-test to satisfy a family-wise error 
rate correction of P < 0.05 FWE.  
2.6.4. Functional connectivity/behaviour relationships 
The RIFG connectivity maps for each participant (as described above) were entered into a 
voxel-wise linear regression analysis to assess between-group differences in the correlation 
between the score of SSRT and functional connectivity. In this set of analysis and due to the 
lack of a previous hypothesis, input parameters to AlphaSim were the same as those we used 
in the subtractive fMRI analysis but including a gray-matter whole brain mask of 163,556 
voxels and the actual smoothing of the data after model estimation. The minimum cluster size 
was determined to be 180 voxels for the one sample t-test and 174 voxels for the two sample 
t-test to satisfy a family-wise error rate correction of P < 0.05 FWE. 
3. Results 
3.1. Behavioral analysis  
Both groups had statistically equivalent distributions for age (HC 34.15 ± 11.12 vs. TBI 
patients 36.86 ± 14.17; P = 0.537) and verbal IQ (HC 117.05 ± 5.87 vs. TBI patients 111.93 
± 10.69; P = 0.120) and were matched on gender (HC 60% vs. TBI patients 71.4% male; P = 
0.493) (Table 1). Successful inhibition to stop trials was close to 50% in all subjects, thus 
Page | 12  
 
proving that the tracking stop mechanism which aimed to ascertain that each subject was 
working at the edge of his/her own inhibitory capacity was successful. Univariate ANCOVAs 
showed no group differences in performance. Nevertheless, the scores of the measure of 
impulsivity showed that TBI patients were more impulsive than HC and that the use of a 
single dose of methylphenidate had a positive effect over inhibition (HC 158.82 ± 115.05 vs. 
TBI placebo 189.14 ± 123.54 vs. TBI drug 174.66 ± 110; P = 0.750).  When the relationship 
between SSRT and attention and executive functioning were assessed, we found no 
significant correlations between any of these measures: SRT (placebo r = 0.294, p = 0.308; 
drug r = -0.046, p = 0.875), SSP (placebo r = -0.323, p = 0.260; drug r = -0.504, p = 0.066), 
IED (placebo r = -0.010, p = 0.973; drug r = -0.411, p = 0.144). 
3.2. Imaging analyses 
3.2.1. DTI analysis 
As expected from a group of patients with DAI, we observed wide-spread reductions in 
fractional anisotropy in the TBI patients when compared to the HC group (Figure 1). 
Statistical peaks for differences were detected in the left inferior parietal cortex (x, y, z = -55, 
-26, 41; t28 = 7.35) and the left posterior (x, y, z = -48, -50, 32; t28 = 7.59) and right anterior 
aspect of the arcuate (x, y, z = 33, 6, 35; t28 = 7.33) signifying wide-spread fronto-parietal 
disconnections. 
3.2.2. Subtractive fMRI analysis 
Intra-groups activations. Activation maps for the groups are shown in Figure 2. HC 
significantly activated a region encompassing the RIFG extending to the anterior insula (peak 
at x, y, z = 32, 20, -6; t19 = 5.29) and the superior parietal cortex (peak at x, y, z = 24, -64, 52; 
t19 = 8.13). Additionally, this group showed significant deactivations in the postcentral gyrus 
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(peak at x, y, z = -36, -22, 48; t19 = 7.07) and rolandic operculum (peak at x, y, z = -40, -22, 
16; t19 = 4.86). We did not find any significant activations or deactivations in the two TBI 
conditions (placebo or drug) at P < 0.05 FWE; we are however showing TBI group 
activations and deactivations at P < 0.005, k > 50 for exploratory purposes only (Figure S1).  
Group differences. When compared with HC, only TBI patients on placebo showed 
significantly reduced activation in the RIFG (peak at x, y, z = 40, 32, -6; t32 = 3.43), 
indicating activity normalization of this region during the methylphenidate condition. We 
used the statistical peak from the RIFG as a seed to explore connectivity differences between 
the groups (HC vs. TBI). 
 
Figure 1. Pattern of fractional anisotropy reductions found in the chronic TBI patients compared to the control 
group. Results are shown on an MNI template and the numbers correspond to the x coordinates.  
 
3.2.3. Psychophysiological interactions analysis 
Intra-groups connectivity maps. Connectivity maps for the groups are shown in Figure S2. 
HC showed negative connectivity between the RIFG and the left anterior cingulate cortex 
(peak at x, y, z = -2, 40, 16; t19 = 4.83), postcentral gyrus (peak at x, y, z = -42, -30, 52; t19 = 
5.29), putamen (peak at x, y, z = -24, 12, -6; t19 = 4.14), cerebellum (peak at x, y, z = -42, -58, 
-34; t19 = 5.42) and the right inferior parietal (peak at x, y, z = 38, -40, 54; t19 = 4.56) and 
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occipital cortices (peak at x, y, z = 42, -82, -10; t19 = 4.20). TBI patients in the placebo 
condition showed positive correlations with the left putamen (peak at x, y, z = -32, -10, -4; t13 
= 5.66) and right cerebellum (peak at x, y, z = 14, -32, -24; t19 = 5.59). Finally, TBI patients 
in the drug condition showed negative correlations with the right inferior temporal cortex 
(peak at x, y, z = 54, -68, -12; t13 = 6.47). 
 
Figure 2. Brain activations and deactivations found during the successful inhibition vs. unsuccessful inhibition 
contrast in the groups. HC significantly activated a region encompassing the RIFG extended to the anterior 
insula and the superior parietal cortex. Additionally, this group showed significant deactivations in the 
postcentral gyrus and rolandic operculum. We did not find any significant activations or deactivations in the 
groups of TBI patients. Results are presented on inflated brains created using the BrainNet tool. The colour bars 
represent t-values. 
 
Group differences. Between-group comparisons revealed that when compared with HC, TBI 
patients on placebo presented increased functional connectivity between the RIFG and two 
regions encompassing the putamen and amygdala bilaterally. Notably, there were no 
significant connectivity differences between HC and TBI patients after the administration of a 
single dose of methylphenidate, which may suggest drug modulation of RIFG connectivity.  
 






Figure 3. Clusters and 
plots of the interactions 
found between SSRT 
scores and the 
connectivity between the 
inferior frontal gyrus 
seed. (A) Clusters and 
plots of the interactions 
found between SSRT 
scores and the 
connectivity between the 
inferior frontal gyrus and 
the medial frontal gyrus, 
(B) Clusters and plots of 
the interactions found 
between SSRT scores 
and the connectivity 
between the inferior 
frontal gyrus and the 
PCC, (C) Clusters and 
plots of the interactions 
found between SSRT 
scores and the 
connectivity between the 
inferior frontal gyrus and 
the angular gyrus, (D) 
Clusters and plots of the 
interactions found 
between SSRT scores 
and the connectivity 
between the inferior 
frontal gyrus and the 
cerebellar vermis, (E) 
Clusters and plots of the 
interactions found 
between SSRT scores 
and the connectivity 
between the inferior 
frontal gyrus and the 
precentral gyrus. TBI 
patients in the placebo 
condition (filled circles, 
solid line) showed 
significant positive 
correlations, while the 
HC (open circles, dotted 
line) displayed a negative 
correlation with SSRT.  
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3.2.4. Connectivity/behaviour relationships 
A significant between-group interaction was found between the SSRT scores and the 
connectivity between the RIFG and a set of regions in the medial surface of the cortex known 
as the DMN (Buckner et al., 2008; Greicius et al., 2003; Raichle et al., 2001). Specifically, 
greater SSRT scores were associated with higher connectivity between RIFG and the left 
medial frontal gyrus (peak at x, y, z = -4, 42, -18; t30 = 5.13), the posterior cingulate cortex 
(PCC) (peak at x, y, z = -8, -74, 34; t30 = 4.64), the angular gyrus (peak at x, y, z = -50, -68, 
40; t30 = 5.06), the cerebellar vermis (peak at x, y, z = -2, -68, -6; t30 = 4.45) and the precentral 
gyrus (peak at x, y, z = -40, 4, 48; t30 = 4.67) in the TBI group in the placebo condition and 
lower connectivity in the HC group (Figure 3). The administration of methylphenidate in the 
patients attenuated all the above interactions with the exception of the PCC. Specifically, 
when patients took methylphenidate we found a significant between-group interaction 
between the SSRT scores and the connectivity between the RIFG and the PCC (peak at x, y, z 
= -10, -66, 30; t30 = 5.40). In other words, greater SSRT scores were associated with higher 
connectivity in the TBI group in the drug condition and lower connectivity in the group of 
HC (Figure 4).  
 
 
Figure 4. Clusters and plots of the interactions found between SSRT scores and the connectivity between the 
inferior frontal gyrus seed and the posterior cingulate cortex. TBI patients in the drug condition (filled circles, 
solid line) showed significant positive correlations, while in HC (open circles, dotted line) the correlations were 
negative.  
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4. Discussion 
The current study aimed to investigate the effect of the administration of a single dose of 
methylphenidate in TBI survivors during the execution of a response inhibition task. We 
found activity abnormalities in the patients as well as compromised functional connectivity 
which we related to performance. The patients also presented with reduced fractional 
anisotropy across most white matter tracts. Both activity and connectivity normalised after 
the administration of methylphenidate. It is important to note that this study included only 
patients in the chronic phase of brain injury and therefore, the alterations we found not only 
highlight the chronic nature of this disorder but also the fact that chronic TBI patients may 
benefit from the use of methylphenidate.  
In keeping with previous work, we found significant reduced fractional anisotropy in 
the patient group providing evidence for the presence of traumatic axonal injury (e.g., 
Kinnunen et al, 2011; Sharp et al, 2011). We also found, in line with previous imaging 
studies on the stop-signal task, that inhibitory control was mediated by the RIFG (e.g., Aron 
et al., 2014; Rubia et al., 2003; Sharp et al., 2010). Furthermore, the improved inhibitory 
response together with the increased activation of this region after the administration of a 
single dose of methylphenidate is consistent with studies showing the benefits of this drug on 
response inhibition in both HC and patients (e.g., ADHD) (Aron et al., 2003; Costa et al., 
2013; Pauls et al., 2012; Rubia et al., 2014). 
The increased functional connectivity we found in the TBI patient group between the 
RIFG and the amygdala and the dorsal striatum overlaps with studies showing enhanced 
connectivity during recovery in this population. Specifically, it has been shown that several 
neural networks present increased connectivity during the first year of recovery after TBI, 
and that this change is disproportionately represented in brain regions belonging to the brain's 
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core networks (i.e., salience, central executive and DMN) (Hillary et al., 2011, 2014). The 
detected increased connectivity may provide evidence for the existence of a mechanism 
compensating for alterations in the networks associated with response inhibition. Along the 
same lines, activity in the basal ganglia has been shown to correlate with SSRT and to be 
more strongly activated in volunteers who perform better in this task (Vink et al., 2005). 
There is also evidence for a direct link between dopamine-receptor availability in the striatum 
and response inhibition (Ghahremani et al., 2012).  
The interaction found between the SSRT scores and the connectivity between the 
RIFG and several regions of the DMN (e.g., medial frontal gyrus, PCC, angular and 
cerebellar vermis) indicates that in TBI patients on placebo, greater connectivity with the 
DMN is associated with longer SSRT or poorer inhibitory control, in agreement with studies 
showing that efficient stopping is associated with the deactivation of the DMN (Bonnelle et 
al., 2012; Raichle and Snyder, 2007; Zhang and Li, 2012). DMN activity is normally high 
when attention is internally directed, and during actions that are reasonably automatic and 
low when responding to an unexpected event in the environment such a stop signal 
(Andrews-Hanna et al., 2010; Fox and Raichle, 2007; Raichle et al., 2001). When responding 
to an unexpected event, this internally focused mode of operation needs to be inhibited, 
allowing the brain to rapidly switch to a controlled mode whereby actions are tightly coupled 
to external events. Therefore, the correlations we found may indicate damage in the networks 
involved in the regulation of the DMN (i.e., salience and central executive networks), which 
might produce ‘interference’ to normal network operations (Bonnelle et al., 2012; Chen et al., 
2013; Gao and Lin, 2012; Jilka et al., 2014; Sharp et al., 2014; Wen et al., 2013). A pattern 
that has also been found in other disorders characterized by lack of inhibitory control 
(Fassbender et al., 2009; van Rooij et al., 2015).  
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Interestingly, the complex relationship we found between the RIFG and the majority 
of the DMN areas in the placebo condition disappears in the drug condition, indicating that 
the administration of methylphenidate may promote a normal balance between the DMN and 
inhibition networks. In this sense, the use of a single dose of methylphenidate has been 
associated with the reduction or “normalization” of abnormally high resting state functional 
connectivity seen in people with ADHD (An et al., 2013; Silk et al., 2016), a population with 
similar inhibitory control problems. Moreover, and in concordance with our findings, a 
number of task-based functional connectivity studies have demonstrated that a single dose of 
methylphenidate improves the suppression of the default mode network (Liddle et al., 2011; 
Peterson et al., 2009; Sripada et al., 2013; Tomasi et al., 2011). It is worth noting that the use 
of methylphenidate did not affect the association between SSRT scores and connectivity 
between the RIFG and the PCC. The PCC has dense connections to many cortical regions, 
and it is considered to be part of the brain‘s structural core (Buckner et al., 2008; Greicius et 
al., 2009; Hagmann et al., 2008). It has also been described as a major DMN node which 
together with its implication in a number of neuropsychiatric and neurodegenerative diseases 
suggests that this region has a central role in cognition (Leech and Sharp, 2014). Moreover, 
the fact that several TBI studies have reported the functional alteration of this area, 
specifically during the execution of inhibition tasks, indicates that this structure may play an 
important role in response inhibition (Bonnelle et al., 2012; Pandit et al., 2013; Sharp et al., 
2011). 
Together, these data suggest that the dysfunctional systems underlying response 
inhibition deficits in TBI patients may be partially restored by methylphenidate which has 
been shown to increase dopamine and noradrenaline neurotransmission by blocking their re-
uptake. Nevertheless and since there is not much of a difference between the group SSRT 
scores when the error is considered, futures studies with bigger sample size should explore 
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the possible existence of subgroups within the study groups (i.e., subgroups with good/bad 
outcomes as well as drug responders). Moreover, it is worth mentioning that we did not find 
any association between SSRT and measures of attention or executive function we used and 
therefore we propose that our results cannot be explained by deficits in these cognitive 
domains. However, in order to know the exact mechanism of action of methylphenidate, 
future studies should assess other cognitive variables that could further elucidate findings 
such as ours. Likewise, future studies and clinical trials should assess the long-term effect of 
methylphenidate in the treatment of impulsivity and other cognitive disorders following TBI. 
One of the strengths of our study is the inclusion of a HC group matched in the main socio-
demographic variables and the utilization of a well-validated measure of response inhibition. 
Nevertheless, several limitations are worth noting. First, although comparable with previous 
studies, it would be important to replicate this study with a larger sample size. Second, it 
should be noted that the methods used to assess functional connectivity cannot determine the 
direction of connectivity. In the future, techniques such as dynamic causal modelling could 
be used. Finally, this study would have benefited from the inclusion and analysis of the sleep 
parameters of the groups given that sleep is a major complaint in chronic TBI sufferers and it 
has been associated with response inhibition deficits (Gardani et al., 2015; Sagaspe et al., 
2007).  
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Table S1.  
Patient GCS ISS APACHE 
II Days on ICU 
Time since injury 
(months) 
Mechanism of injury 
1 5 25 21 18 36 Road traffic accident 
2 7 26 16 5 25 Road traffic accident 
3 10 9 19 7 32 Vehicle-pedestrian collision 
4 8 9 13 8 27 Assault 
5 12 17 14 1 17 Fall 
6 5 25 11 24 14 Road traffic accident 
7 7 41 10 3 32 Vehicle-pedestrian collision 
8 14 18 12 - 9 Fall 
9 8 9 13 24 7 Road traffic accident 
10 6 34 22 5 11 Road traffic accident 
11 7 13 13 3 25 Road traffic accident 
12 - - - - 41 Road traffic accident 
13 9 20 - 6 7 Fall 
14 8 18 10 10 8 Road traffic accident 
M: male; F: female; GCS: Glasgow Coma Scale; ISS: Injury Severity Scale; APACHE II: Acute Physiology and Chronic 
Health Evaluation II. ICU: Intensive Care Unit. GCS, ISS and days on ICU were not available for one patient. APACHE II 
was not available for two subjects. 
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Figure S1. Brain activations and deactivations during the successful inhibition vs. unsuccessful inhibition 
contrast in the TBI patients. Results are displayed at P < 0.005 k > 50. Results are presented on inflated brains 





Figure S2. Within-group positive and negative functional connectivity maps calculated from the seed found in 
the subtractive analysis (right IFG). Results are displayed at P < 0.05 FWE. Results are presented on inflated 
brains created using the BrainNet tool. The colour bars represent t-values.  
 
 
 
